PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-0.99%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$82.7M
AUM Growth
+$82.7M
(-44%)
Cap. Flow
-$56M
Cap. Flow
% of AUM
-67.65%
Top 10 Holdings %
Top 10 Hldgs %
74.96%
Holding
65
New
9
Increased
5
Reduced
11
Closed
15
Top Buys
| 1 |
ICU Medical
ICUI
|
$3.48M |
| 2 |
Castle Biosciences
CSTL
|
$3.34M |
| 3 |
Masimo
MASI
|
$3.15M |
| 4 |
Bruker
BRKR
|
$2.07M |
| 5 |
Bioventus
BVS
|
$1.61M |
Top Sells
| 1 |
Exact Sciences
EXAS
|
$33.3M |
| 2 |
Lyra Therapeutics
LYRA
|
$8.79M |
| 3 |
DexCom
DXCM
|
$4.16M |
| 4 |
Viking Therapeutics
VKTX
|
$3.27M |
| 5 |
Inspire Medical Systems
INSP
|
$3.22M |
Sector Composition
| 1 | Healthcare | 93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $10.5M | 6.62% | 230,093 -31,580 | -12% | -$1.43M |
|
2
Glaukos
GKOS
$5.5B
| $10.3M | 6.52% | 87,000 +8,000 | +10% | +$947K |
|
3
Intuitive Surgical
ISRG
$170B
| $8.41M | 5.32% | 18,900 -5,150 | -21% | -$2.29M |
|
4
Natera
NTRA
$23.1B
| $7.31M | 4.63% | 67,500 -4,106 | -6% | -$445K |
|
5
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $5.77M | 3.65% | 787,000 +207,000 | +36% | +$1.52M |
|
6
Quanterix
QTRX
$211M
| $5.41M | 3.42% | 409,334 +33,349 | +9% | +$441K |
|
7
LivaNova
LIVN
$3.08B
| $4.3M | 2.72% | 78,350 -11,801 | -13% | -$647K |
|
|
8
ICU Medical
ICUI
$3.15B
| $3.48M | 2.2% | +29,334 | New | +$3.48M |
|
|
9
Castle Biosciences
CSTL
$696M
| $3.34M | 2.11% | +153,386 | New | +$3.34M |
|
10
Pulmonx
LUNG
$69.7M
| $3.25M | 2.06% | 512,964 +46,177 | +10% | +$293K |
|
|
11
Masimo
MASI
$7.59B
| $3.15M | 1.99% | +25,000 | New | +$3.15M |
|
12
Alphatec Holdings
ATEC
$2.35B
| $2.08M | 1.32% | 199,000 -121,054 | -38% | -$1.27M |
|
|
13
Bruker
BRKR
$5.16B
| $2.07M | 1.31% | +32,500 | New | +$2.07M |
|
|
CUTR
14
DELISTED
Cutera, Inc.
CUTR
| $1.76M | 1.11% | 1,165,799 +87,072 | +8% | +$131K |
|
15
Tandem Diabetes Care
TNDM
$845M
| $1.63M | 1.03% | 40,500 -2,000 | -5% | -$80.6K |
|
|
16
Bioventus
BVS
$495M
| $1.61M | 1.02% | +280,000 | New | +$1.61M |
|
|
IMDX
17
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $1.46M | 0.92% | 495,345 -28,583 | -5% | -$84.3K |
|
18
STAAR Surgical
STAA
$1.36B
| $1.43M | 0.9% | +30,000 | New | +$1.43M |
|
19
ZimVie
ZIMV
$532M
| $1.28M | 0.81% | 70,000 -3,095 | -4% | -$56.5K |
|
20
InspireMD
NSPR
$102M
| $1.12M | 0.71% | 450,517 | – | – |
|
21
Metagenomi
MGX
$65.3M
| $1.04M | 0.66% | 270,618 -190,665 | -41% | -$732K |
|
22
Elanco Animal Health
ELAN
$9.12B
| $817K | 0.52% | 56,603 -136,647 | -71% | -$1.97M |
|
23
Twist Bioscience
TWST
$1.63B
| $493K | 0.31% | +10,000 | New | +$493K |
|
|
NARI
24
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $482K | 0.3% | +10,000 | New | +$482K |
|
25
GeneDx Holdings
WGS
$3.72B
| $261K | 0.17% | +10,000 | New | +$261K |
|